Christopher Del Orefice Resmed Inc (RSMDF) insider trading activity

Christopher Del Orefice is Director of RESMED INC. Currently has a direct ownership of 1,350 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 20, 2024, when has been sold 1,083 shares (ResMed Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.35K

405.62% 3M change

n/a 12M change

Total Value Held $0

Christopher DelOrefice Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 20 2024	BUY Grant, award, or other acquisition	-	1,083 Added 44.51%	1,350 ResMed Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	-	267 Added 50.0%	267 ResMed Common Stock

Also insider at

BDX

BECTON DICKINSON & CO Healthcare

EVP & Chief Financial Officer